| 2026-08-05 | 10-Q | 10.3 | Charles River Laboratories International, Inc. Form of Performance Share Unit granted under the 2026 Long-Term Incentive Plan - United States |
|---|
| 2026-08-05 | 10-Q | 10.2 | Charles River Laboratories International, Inc. Form of Restricted Stock Unit granted under the 2026 Long-Term Incentive Plan - United States |
|---|
| 2026-05-11 | 8-K | 10.1 | 2026 Long-Term Incentive Plan |
|---|
| 2026-02-18 | 10-K | 10.20 | Letter Agreement by and between Charles River Laboratories International, Inc. and Birgit Girshick, dated as of January 6, 2026 |
|---|
| 2026-02-18 | 10-K | 10.13 | Amendment No. 2 to the Amended and Restated Employment Agreement by and between James C. Foster and Charles River International, Inc., dated January 6, 2026 |
|---|
| 2026-02-18 | 8-K | 10.1 | Employment Offer Letter between Charles River Laboratories, Inc. and Glenn Coleman, dated as of February 12, 2026. |
|---|
| 2025-08-06 | 10-Q | 10.1 | Amendment to the Amended and Restated Employment Agreement by and between James C. Foster and Charles River International, Inc., dated May 20, 2025 |
|---|
| 2025-05-07 | 8-K | 10.1 | Cooperation Agreement, by and among the Company and Elliott Investment Management L.P., Elliott Associates, L.P. and Elliott International, L.P., dated as of May 6, 2025 |
|---|
| 2025-02-19 | 10-K | 10.13 | Charles River Laboratories amended and restated Deferred Compensation Plan, as amended |
|---|
| 2025-02-19 | 10-K | 10.7 | Charles River Executive Separation Plan dated December 05, 2024 |
|---|
| 2024-12-13 | 8-K | 10.1 | Tenth Amended and Restated Credit Agreement, dated as of December 13, 2024, among Charles River Laboratories International, Inc., the Subsidiary Borrowers party thereto, the lenders party thereto, JPMorgan Chase Bank, N.A. as administrative agent, and the other agents party thereto. |
|---|
| 2024-02-14 | 10-K | 10.6 | Charles River Laboratories International, Inc. Form of Restricted Stock Unit granted under the 2018 Incentive Plan |
|---|
| 2024-02-14 | 10-K | 10.2 | Charles River Laboratories International, Inc. Amended and Restated 2018 Incentive Plan, dated March 20, 2018, as amended November 21, 2023 |
|---|
| 2023-05-11 | 10-Q | 10.1 | Second Amendment to the Ninth Amended and Restated Credit Agreement, dated March 30, 2023, among Charles River Laboratories International, Inc., the Subsidiary Borrowers party thereto, the lenders party thereto, JPMorgan Chase Bank, N.A., as administrative agent, and the other agents party thereto |
|---|
| 2022-05-04 | 10-Q | 10.1 | Employment Offer Letter between Charles River Laboratories, Inc. and Flavia Pease, dated as of March 4, 2022 |
|---|
| 2022-02-16 | 10-K | 10.18 | Agreement between David Ross Smith and Charles River Discovery Research Services UK Limited dated February 15, 2022 |
|---|
| 2021-12-27 | 8-K | 10.2 | Charles River Laboratories International, Inc. Performance Share Unit Award dated December 25, 2021 granted to Joseph W. LaPlume |
|---|
| 2021-12-27 | 8-K | 10.1 | Charles River Laboratories International, Inc. Restricted Stock Unit Award dated December 25, 2021 granted to Joseph W. LaPlume |
|---|
| 2021-05-04 | 10-Q | 10.3 | Charles River Laboratories amended and restated Deferred Compensation Plan, as amended |
|---|
| 2021-05-04 | 10-Q | 10.2 | Executive Incentive Compensation Program effective January 1, 2021 |
|---|
| 2021-05-04 | 10-Q | 10.1 | Agreement between David Ross Smith and Charles River Discovery Research Services UK Limited effective December 1, 2020 |
|---|
| 2021-04-23 | 8-K | 10.1 | Ninth Amended and Restated Credit Agreement, dated as of April 21, 2021, among Charles River Laboratories International, Inc., the Subsidiary Borrowers party thereto, the lenders party thereto, JPMorgan Chase Bank, N.A. as administrative agent, and the other agents party thereto. |
|---|
| 2021-02-17 | 8-K | 10.1 | Form of Support Agreement |
|---|
| 2020-08-05 | 10-Q | 10.3 | Charles River Laboratories International, Inc. Form of Performance Share Unit granted under the 2018 Incentive Plan |
|---|
| 2020-08-05 | 10-Q | 10.2 | Charles River Laboratories International, Inc. Form of Restricted Stock Unit granted under the 2018 Incentive Plan |
|---|
| 2020-08-05 | 10-Q | 10.1 | Charles River Laboratories International, Inc. Form of Non-Qualified Stock Option granted under the 2018 Incentive Plan |
|---|
| 2020-05-07 | 10-Q | 10.1 | Charles River Laboratories International, Inc. Amended and Restated 2018 Incentive Plan, dated May 6, 2020 |
|---|
| 2019-11-06 | 10-Q | 10.3 | Charles River Laboratories International, Inc. Third Amendment dated November 4, 2019 relating to the Eighth Amended and Restated Credit Agreement dated March 26, 2018 |
|---|
| 2019-11-06 | 10-Q | 10.2 | Charles River Laboratories International, Inc. Second Amendment dated September 25, 2019 relating to the Eighth Amended and Restated Credit Agreement dated March 26, 2018 |
|---|
| 2019-11-06 | 10-Q | 10.1 | Agreement between David Johst and Charles River Laboratories, Inc. effective July 26, 2019 |
|---|
| 2019-07-31 | 10-Q | 10.2 | Charles River Laboratories International, Inc. Form of Restricted Stock Unit granted under the 2018 Incentive Plan |
|---|
| 2019-07-31 | 10-Q | 10.1 | Charles River Laboratories International, Inc. Form of Non-Qualified Stock Option granted under the 2018 Incentive Plan |
|---|
| 2018-11-07 | 10-Q | 10.3 | Consulting Agreement between Davide Molho and Charles River Laboratories, Inc. dated August 28, 2018 |
|---|
| 2018-11-07 | 10-Q | 10.2 | Separation Agreement between Davide Molho and Charles River Laboratories, Inc. dated August 1, 2018 (revised on August 28, 2018) |
|---|
| 2018-11-07 | 10-Q | 10.1 | Separation Memorandum between Davide Molho and Charles River Laboratories, Inc. dated August 1, 2018 (revised on August 28, 2018) |
|---|
| 2018-05-10 | 10-Q | 10.2 | Charles River Laboratories International, Inc. 2018 Incentive Plan dated March 20, 2018 |
|---|
| 2018-03-26 | 8-K | 10.1 | Eighth Amended and Restated Credit Agreement, dated as of March 26, 2018, among Charles River Laboratories International, Inc., the Subsidiary Borrowers party thereto, the lenders party thereto, JPMorgan Chase Bank, N.A. as administrative agent, and the other agents party thereto. |
|---|
| 2018-02-13 | 8-K | 10.1 | Support Agreement, dated as of February 12, 2018, by and among Charles River Laboratories International, Inc., Avista Capital Holdings, L.P., Avista Capital Partners IV, L.P., Avista Capital Partners IV (Offshore), L.P. and ACP Mountain Co-Invest LLC and the other parties thereto.* |
|---|
| 2017-05-10 | 10-Q | 10.1 | Charles River Laboratories International, Inc. Incentive Compensation Plan |
|---|
| 2017-02-14 | 10-K | 10.7 | Charles River Laboratories International, Inc. Form of Restricted Stock Unit granted under the 2016 Incentive Plan |
|---|
| 2017-02-14 | 10-K | 10.6 | Charles River Laboratories International, Inc. Form of Restricted Stock Unit granted under the 2007 Incentive Plan |
|---|
| 2017-02-14 | 10-K | 10.4 | Charles River Laboratories International, Inc. Form of Stock Option granted under the 2016 Incentive Plan |
|---|
| 2016-08-03 | 10-Q | 10.1 | Charles River Laboratories International, Inc. 2016 Incentive Plan |
|---|
| 2016-05-04 | 10-Q | 10.1 | Non-Employee Directors Deferral Plan dated April 5, 2016 |
|---|
| 2016-04-05 | 8-K | 10.1 | Seventh Amended and Restated Credit Agreement, dated as of March 30, 2016, among Charles River Laboratories International, Inc., the Subsidiary Borrowers party thereto, the lenders party thereto, JPMorgan Chase Bank, N.A. as administrative agent, and the other agents party thereto. |
|---|
| 2016-02-12 | 10-K | 10.18 | Commitment Letter dated January 6, 2016 among Charles River Laboratories International, Inc., J.P. Morgan Securities LLC and JPMorgan Chase Bank, N.A. |
|---|
| 2016-02-12 | 10-K | 10.17 | Support Agreement dated January 6, 2016 among Charles River Laboratories International, Inc., American Capital Equity II, American Capital Equity III and certain other stockholders of WRH, Inc. |
|---|
| 2016-02-12 | 10-K | 10.16 | Agreement between David Smith and Charles River Laboratories, Inc. dated March 3, 2015 |
|---|
| 2016-02-12 | 10-K | 10.8 | First Amendment to Charles River Laboratories International, Inc. Sixth Amended and Restated Credit Agreement dated July 29, 2015 |
|---|
| 2016-02-12 | 10-K | 10.4 | Executive Incentive Compensation Plan dated January 1, 2016 |
|---|
| 2015-07-30 | 10-Q | 10.1 | Charles River Laboratories International, Inc. Amendment No. 1 to Sixth Amended and Restated Credit Agreement dated July 29, 2015. Filed herewith. |
|---|
| 2015-04-30 | 10-Q | 10.4 | Thomas F. Ackerman Performance Award Agreement dated February 27, 2015. Filed herewith. |
|---|
| 2015-04-30 | 10-Q | 10.3 | Charles River Laboratories International, Inc. Form of Performance Share Unit Agreement granted under the 2007 Incentive Plan. Filed herewith. |
|---|
| 2015-04-30 | 10-Q | 10.2 | Charles River Laboratories International, Inc. Form of Non-Qualified Stock Option Agreement granted under the 2007 Incentive Plan. Filed herewith. |
|---|
| 2015-04-30 | 10-Q | 10.1 | Charles River Laboratories International, Inc. Form of Restricted Stock Unit Agreement granted under the 2007 Incentive Plan. Filed herewith. |
|---|
| 2015-04-22 | 8-K | 10.1 | Sixth Amended and Restated Credit Agreement, dated as of April 22, 2015, among Charles River Laboratories International, Inc., the Subsidiary Borrower party thereto, the lenders party thereto, JPMorgan Chase Bank, N.A. as administrative agent and the other agents party thereto. |
|---|
| 2015-02-17 | 10-K | 10.23 | Agreement between Dr. Nancy Gillett and Charles River Laboratories, Inc. effective January 1, 2015 |
|---|
| 2015-02-17 | 10-K | 10.13 | Charles River Laboratories International, Inc. 2007 Incentive Plan, as amended |
|---|
| 2013-07-31 | 10-Q | 10.1 | Fifth Amended and Restated Credit Agreement, dated as of May 29, 2013, among Charles River Laboratories International, Inc., the Subsidiary Borrowers party thereto, the lenders party thereto, JPMorgan Chase Bank, N.A. as administrative agent and the other agents party thereto. |
|---|
| 2013-05-29 | 8-K | 10.1 | Fifth Amended and Restated Credit Agreement, dated as of May 29, 2013, among Charles River Laboratories International, Inc., the Subsidiary Borrower party thereto, the lenders party thereto, JPMorgan Chase Bank, N.A. as administrative agent and the other agents party thereto. |
|---|
| 2013-05-08 | 10-Q | 10.4 | ADDENDUMTOTHISPENSION |
|---|
| 2013-05-08 | 10-Q | 10.3 | PENSIONCOMMITMENT |
|---|
| 2013-05-08 | 10-Q | 10.2 | INSURANCEPOLICY2 |
|---|
| 2013-05-08 | 10-Q | 10.1 | INSURANCEPOLICY1 |
|---|
| 2013-02-27 | 10-K | 10.18 | Employment agreement between Dr. Jorg Geller and Charles River Germany GmbH & Co. |
|---|
| 2012-08-07 | 10-Q | 10.1 | Charles River Laboratories Amended and Restated Deferred Compensation Plan amended December 2, 2008, July 20, 2011, October 27, 2011 and July 17, 2012. Filed herewith. |
|---|
| 2012-02-27 | 10-K | 10.13 | Charles River Laboratories International, Inc. 2007 Incentive Plan amended March 18, 2009 and March 22, 2011 |
|---|
| 2012-02-27 | 10-K | 10.11 | Charles River Laboratories amended and restated Deferred Compensation Plan amended December 2, 2008, July 20, 2011 and October 27, 2011 |
|---|
| 2011-09-23 | 8-K | 10.1 | Fourth Amended and Restated Credit Agreement, dated as of September 23, 2011, among Charles River Laboratories International, Inc., the Subsidiary Borrower party thereto, the lenders party thereto, JPMorgan Chase Bank, N.A. as administrative agent and the other agents party thereto. |
|---|
| 2011-05-04 | 10-Q | 10.1 | Letter Agreement confirming Fixed Dollar Accelerated Share Repurchase Transaction between Charles River Laboratories International, Inc. and Morgan Stanley & Co. Incorporated dated February 24, 2011. Filed herewith. |
|---|
| 2011-02-25 | 8-K | 10.1 | Incremental Assumption Agreement and Amendment, dated as of February 24, 2011, among Charles River Laboratories International, Inc., as Parent Borrower, certain subsidiaries of the Parent Borrower party thereto, the lenders party thereto, JPMorgan Chase Bank, N.A. as administrative agent, Bank of America, N.A., as syndication agent, and the other agents party thereto. |
|---|
| 2011-02-23 | 10-K | 10.17 | Dr. Davide Molho |
|---|
| 2010-11-04 | 10-Q | 10.1 | Letter Agreement confirming Fixed Dollar Accelerated Share Repurchase Transaction between Charles River Laboratories International, Inc. and Morgan Stanley & Co. Incorporated dated August 26, 2010. Filed herewith. |
|---|
| 2010-08-31 | 8-K | 10.1 | Third Amended and Restated Credit Agreement, dated as of August 26, 2010, among Charles River Laboratories International, Inc., the Subsidiary Borrower party thereto, the lenders party thereto, JPMorgan Chase Bank, N.A. as administrative agent, Bank of America, N.A., as syndication agent, and RBS Citizens National Association, Societe Generale and Wells Fargo Bank, National Association, as co-documentation agents. |
|---|
| 2010-08-03 | 10-Q | 10.1 | Charles River Laboratories Corporate Officer Separation Plan (revised April 2010). Filed herewith.+ |
|---|
| 2009-05-06 | 10-Q | 10.1 | Charles River Laboratories International, Inc. 2007 Incentive Plan, as amended March 2009. + Filed herewith. |
|---|
| 2009-02-23 | 10-K | 10.13 | Deferred Compensation Plan.+ |
|---|
| 2009-02-23 | 10-K | 10.8 | Executive Incentive Compensation Plan, as amended.+ |
|---|
| 2009-02-23 | 10-K | 10.7 | Form of Change in Control Agreement.+ |
|---|
| 2009-02-23 | 10-K | 10.2 | 1999 Charles River Laboratories Corporate Officer Separation Plan.+ |
|---|
| 2009-02-23 | 10-K | 10.1 | Severance Agreement between Charles River Laboratories, Inc. and Real H. Renaud, dated January 20, 1992, amended December 15, 2008. + |
|---|